Figure 2: Treatment goals across total cardiovascular disease risk categories applied to the Saudi population. Apo-B: Apolipoprotein B, ASCVD: Atherosclerotic cardiovascular disease, BMI: Body mass index, BP: Blood pressure, CKD: Chronic kidney disease, DM: Diabetes mellitus, eGFR: Estimated glomerular filtration rate, FH: Familial hypercholesterolemia, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, non-HDL-C: Nonhigh-density lipoprotein cholesterol, SCORE: Systematic Coronary Risk Estimation, T1DM: Type 1 diabetes mellitus, T2DM: Type 2 diabetes mellitus, TC: Total cholesterol